As HIF-2a is a known driver of stem cell characteristics in glioma and other tumor forms [31,23,[32], [33], [34]], we next tested whether effects of DLK1 on glioma cell behavior were mediated by HIF-2a. This evidence concerns the gene EPAS1 and central nervous system cancer.